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1  |  INTRODUC TION
Treatment burden is defined as ‘the impact of health care on 
patients’ functioning and wellbeing’ (Eton et al., 2012, p. 40). It 
accounts for the work, that is, self- care and self- monitoring, 
managing therapeutic regimens, organising doctor visits, and man-
aging transitions from hospital to home, delegated by health pro-
fessionals to chronically ill patients. Poor health and well- being are 
considered the predominant consequences of treatment burden 
in patients with long- term illness (Eton et al., 2019; Lippiett et al., 
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Objective: To describe the severity of treatment burden in surgically treated colorec-
tal cancer (CRC) patients and examine associations between treatment burden and 
demographic and clinical variables.
Methods: This	 cross-	sectional	 study	 recruited	134	patients	diagnosed	with	Dukes’	
stage	A-	C	CRC	between	2016	and	2018	who	underwent	curative	surgery.	The	Patient	
Experience with Treatment and Self- management (PETS) questionnaire assessed 
treatment burden domains of ‘workload’, ‘stressors’ and ‘impact’ between 6 weeks 
and 18 months after primary surgery.
Results: Highest scores were observed for difficulty with healthcare services (median 
score 33.3), physical and mental fatigue (median score 30.0) and medical information 
(median score 26.8). Younger age, low education level or no cohabitants were signifi-
cantly associated with higher workload PETS scores (p	<	0.05,	0.013,	p = 0.047, re-
spectively). Higher PETS stressors scores were significantly associated with younger 
age (p = 0.006), lower education level (p = 0.016), and high comorbidity (p = 0.013). 
Higher PETS impact scores were significantly associated with the female sex 
(p	=	0.050),	younger	age	(p = <0.001– 0.003), lower education (p = 0.003), no cohabit-
ants (p = 0.003), high comorbidity (p	=	0.003)	and	cancer	stage	Dukes	A	(p = 0.004).
Conclusions: A	 seamless	 and	 supportive	 healthcare	 system	beyond	 hospitalisation	
targeting CRC subpopulations in danger of high treatment burden may improve pa-
tients’ self- management experience.
K E Y W O R D S
colorectal cancer, patient- reported outcome, post- discharge, supportive care, treatment 
burden
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2019;	 Tran	 et	 al.,	 2015).	Moreover,	 non-	adherence	 to	 treatment	
(May	 et	 al.,	 2014),	 costly	 re-	admissions	 (Spencer-	Bonilla	 et	 al.,	
2017) and burden placed on significant others, add to the magni-
tude of burden (Boehmer et al., 2018). The concept of treatment 
burden is highly relevant to cancer patients. In a recent systematic 
review, experienced treatment burden in lung cancer patients was 
associated with managing treatment side effects, burdensome 
cognitive decision- making processes and multiple treatment ap-
pointments, among other factors (Lippiett et al., 2019). Cheng and 
Levy (2016) found in breast cancer patients that a more severe 
cancer stage was associated with a higher number of healthcare 
service encounters, which again translated into higher experi-
enced treatment burden. Eton et al. (2019) found that a low ed-
ucation level was associated with increased physical and mental 
exhaustion	due	to	self-	management	in	cancer	patients.	Moreover,	
these authors observed that treatment burden was related to the 
number of chronic conditions experienced through limitations 
imposed on patients’ social role and function, thus negatively af-
fecting	health-	related	quality	of	life	(HRQOL).	In	non-	cancer	pop-
ulations, treatment burden is associated with being female and 
being	younger	(Duncan	et	al.,	2018)	and	having	a	higher	number	of	
chronic conditions (Eton et al., 2017; Rogers et al., 2017).
CRC ranks as the 3rd most common cause of cancer- related 
death irrespective of gender, with a particular increasing incidence 
in	 ageing	 populations	 (Cancer	 Registry	 of	 Norway,	 2017).	 The	
post- hospital discharge may represent a vulnerable time for CRC 
survivors because of treatment side effects experienced at home 
and emotional distress resulting from cancer and its treatment 
(Jakobsson	et	al.,	2017).	In	a	systematic	review,	51%	of	support	care	
requirements following CRC treatment concerned information and 
education, including communication issues between patients and 
healthcare providers (Kotronoulas et al., 2017).
Treatment burden in CRC patients remains unexplored, and to 
our knowledge, aspects of treatment burden has not yet been in-
vestigated	 in	 patients	 surgically	 treated	 for	CRC.	Additionally,	 the	
novelty of this study lies in the application of the Patient Experience 
with Treatment and Self- management (PETS) questionnaire, one of 
few instruments validated for treatment burden assessment (Eton 
et al., 2017) and yet to be used in a CRC patient population (Spencer- 
Bonilla et al., 2017). The primary purpose of the study was to de-
scribe the treatment burden experienced by CRC patients surgically 
treated with curative intent and to explore whether there were any 
associations between treatment burden and demographics, clinical 
characteristics or time since primary treatment.
2  |  METHODS
2.1  |  Study design
The study applied a retrospective cross- sectional design and in-
cluded patients treated for CRC with curative intent who underwent 
surgery between June 2016 and June 2018.
2.2  |  Study context and participants
In	 Norway,	 routine	 primary	 treatment	 of	 patients	 with	 non-	
metastatic resectable CRC is based on surgical resection, with ad-
juvant (i.e. postoperative) chemotherapy offered to most lymph 
node- positive colon cancer patients; neoadjuvant (i.e. pre- operative) 
chemo- radiation treatment is selectively employed in some rectal 
cancer patients (Schmoll et al., 2012). CRC survivors are enrolled in a 
coordinated	treatment	pathway	from	diagnosis.	After	primary	treat-
ment, patients with rectal cancer are usually scheduled for regular 
hospital appointments; in the case of colon cancer, patients are fol-
lowed	up	by	their	general	practitioner	(GP),	with	expected	imaging	
at the hospital.
One	 hundred	 sixty-	six	 patients	 surgically	 treated	 for	 CRC	 be-
tween June 2016 and June 2018 were identified from the electronic 
hospital records of a university hospital in the southwestern part 
of	Norway	with	a	primary	catchment	population	of	approximately	
380,000 individuals. Eligible patients were between 18 and 80 years 
of age, had been surgically treated for either colon or rectal cancer 
with	curative	intent,	had	no	distant	metastasis	(i.e.	Dukes’	class	A-	C	
or stage I– III), had undergone primary surgery 2 months— 2 years 
prior,	and	were	able	to	communicate	orally	and	in	written	Norwegian.	
Excluded were patients diagnosed with metastatic CRC (Stage IV 
disease), patients who had experienced severe postoperative sur-
gical	 complications	 (i.e.	 Grade	 >3	 according	 to	 the	 Clavien-	Dindo	
Surgical Complications Score (Clavien et al., 2009)), and patients 
with mental illness or cognitive impairment that made participation 
impossible.	The	main	reasons	for	non-	eligibility	were	age	(≥	80	years)	
or metastatic cancer.
2.3  |  Ethical considerations
The	study	was	approved	by	 the	Regional	Committees	 for	Medical	
and	Health	Research	Ethics	 (No.	2017/284).	Eligible	patients	were	
offered both written and oral information about the study, including 
the required secure handling of the database. Participants provided 
written consent to participate and had the right to withdraw from 




The study uses the Patient Experience with Treatment and Self- 
management (PETS) questionnaire, a generic scale developed by 




version	 have	been	 reported	 elsewhere	 (Husebø	 et	 al.,	 2018).	 This	
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study utilises a 48- item version measuring treatment burden across 
nine	dimensions	 (Eton	et	 al.,	 2017).	Of	 the	nine	PETS	dimensions,	
the	dimensions	‘medical	information	(MINF)’,	‘medications	(MEDS)’,	
‘medical	 appointments	 (MAP)’	 and	 ‘monitoring	 health	 (MH)’	 per-
tains to workload, while the dimensions ‘relationship with others 
(ROL)’,	 ‘medical	 and	health	care	expenses	 (MEXP)’	 and	 ‘difficulties	
with health care services (HCS)’ pertain to stressors aggravating bur-
den.	The	dimensions	 ‘role	and	social	activity	 limitations’	 (RAL)	and	
‘physical	and	mental	fatigue	from	self-	management’	(PMF)	pertains	
to the impact	of	burden.	Responses	are	given	on	either	a	4-	or	a	5-	
point Likert scale, with a recall period of 4 weeks. Each dimension 
is scored separately. Raw scores are converted so that each domain 
scale has a scoring range of 0– 100, with a higher score indicating 
a	 higher	 treatment	 burden	 (Rogers	 et	 al.,	 2017).	 A	 total	 score	 is	
not available for the PETS, and users of the instrument are recom-
mended to apply the subscales relevant to the research or clinical 
practice (Eton et al., 2017).
The PETS has shown good psychometric properties in prospec-
tive	 studies	of	 chronically	 ill	 patients	 conducted	 in	 the	USA	 (Eton	
et al., 2017, 2019; Rogers et al., 2017). This is the first study to use 
the PETS in a cancer population outside the United States and in 
a	Norwegian	healthcare	services	context.	Reliability	 testing	of	 the	
Norwegian	 version	 using	 data	 generated	 from	 the	 study	 sample	




study that included items about age, gender, living conditions, edu-
cation and employment.
2.4.3  |  Clinical	data
Clinical data concerning diagnosis, cancer stage, treatment received, 
number of comorbidities and date of primary surgical treatment were 
retrieved from hospital records. The variable ‘time since primary sur-
gical treatment’ was coded into three categories: ‘<6 months since 
primary surgery’, ‘6– 12 months since primary surgery’ and ‘12– 
18 months since primary surgery’.
2.5  |  Data collection
The study applied two different recruitment procedures. Patients 
surgically treated between June 2016 and September 2017 were 
recruited by a mailed request containing an information letter, a 
consent form and the survey inventory. Patients surgically treated 
between	October	2017	and	June	2018	were	consecutively	contacted	
by a study nurse during postoperative follow- up appointments at 
the surgical outpatient clinic. Patients were informed about study 
aims and principles of voluntary participation and confidentiality. 
Written information was provided to patients, including the consent 
form and the survey inventory, which respondents were asked to 
complete	at	home.	Non-	responders	received	one	reminder	by	letter	
2 weeks following the initial invitation.




den dimension were missing, the missing values were imputed with 
the mean of the remaining items from the same subscale (Eton et al., 
2017). Beyond that, we used all available cases for each analysis and 
indicated the number of patients included for each result. The main 
reason for missing data was that the item was deemed not applica-
ble. Study variables were described via the frequency, percentage, 
median and interquartile range (IQR). The Kolmogorov– Smirnov test 
revealed	non-	normally	distributed	data.	Associations	between	treat-
ment burden dimensions and patient and treatment variables were 
estimated using univariable and multivariable regression models. 
Due	to	the	skewness	observed	in	the	treatment	burden	dimensions,	
Poisson regression models were used, with standard errors calcu-
lated	by	the	sandwich	method	(Zou,	&	Donner,	2013).	The	reported	
effects are exponentiated regression coefficients, which may be in-
terpreted	as	 ratios	of	means	 (RM).	These	 are	presented	with	95%	
confidence intervals (CI) and with p values derived from Wald tests. 
If	RM	>	1,	the	mean	scores	of	the	group	in	question	is	more	extensive	
than	of	the	comparator	group,	and	vice	versa	if	RM	<	1.	Employment	
status was not included in the multiple regression analyses, since it 
might have been affected by treatment burden (i.e. higher treatment 
burden equals reduced ability to work). Regression modelling was 
performed in Stata version 16 with the Poisson function and apply-
ing the vce(robust) option (StataCorp, 2019).




ten consent and the survey inventory, resulting in a response rate 
of	84%.	Data	on	non-	participants	were	not	collected	due	to	ethics	
legislation.
3.1  |  Patient characteristics
Descriptive	demographic	and	clinical	data	are	displayed	in	Table	1.	
Among	 respondents,	 there	 were	more	men	 (N	 =	 83,	 62.9%)	 than	
4 of 11  |     HUSEBØ Et al.
women, and the median age was 67 (range 40– 78) years. The major-
ity	 of	 respondents	were	 ethnic	Norwegians	 (N	 =	 131,	 97.8%)	 and	
lived with a partner or significant other (N	=	115,	82.9%).	Fifty	per	
cent (n	=	67)	of	 respondents	had	received	higher	education.	Most	
respondents were currently not employed (N	=	82,	61.2%).	Nearly	
half (N	=	62,	46.3%)	were	surgically	treated	less	than	6	months	be-
fore	 responding	 to	 the	 survey.	 Most	 were	 diagnosed	 with	 colon	
cancer (N	 =	80,	59.7%),	 of	whom	70.9%	 (N	 =	95)	had	Dukes’	B	or	
C.	Approximately	69%	(N = 92) of patients had surgery as the only 
treatment modality, without any additional systemic cancer treat-
ment.	Multimorbidity	was	documented	 in	nearly	75%	(N = 100) of 
respondents,	with	43%	(N	=	59)	having	two	or	more	chronic	condi-
tions in addition to cancer.
Treatment burden characteristics are presented in Table 2. In the 
workload domain, ‘medical information’ and ‘monitoring health’ had 
the	highest	scores	(median	scores	≥20.0),	while	the	highest	score	for	
treatment burden stressors was observed for the dimension ‘diffi-
culty	with	health	care	services’	(median	scores	≥30.0).	In	the	impact	
TA B L E  1 Demographic	and	clinical	characteristics	of	the	study	
sample (N = 134)
Characteristics N (%)











Living alone 23 (17.2)
Living with partner 107 (79.8)
Living with others 8 (3.0)
Education






Part time 20 (14.9)
No 82 (61.2)
Missing 4 (3.0)
Time since primary surgical treatment
<6 months 62 (46.3)
6– 12 months 41 (30.6)


























TA B L E  2 Treatment	burden	in	colorectal	cancer	patients	as	
measured by the PETS questionnaire
Treatment burden 
dimensions N Median (IQR)
Workload of health care
Medical	information 110 26.8 (14.3– 39.3)
Medications 76 3.4	(0.0–	25.0)
Medical	appointments 125 4.1 (0.0– 20.8)
Monitoring	health 114 25.0	(0.0–	37.5)
Stressors aggravating the burden






80 33.3 (7.1– 42.9)
Impact of burden
Role and social activity 
limitations
126 12.5	(0.0–	34.4)




treatment and self- management.
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domain, ‘physical and mental fatigue’ from self- management had the 
highest	score	(≥30.0).
3.2  |  Workload of health care and its associations 
with demographic and clinical factors
In Table 3, the unadjusted and adjusted results from the regres-
sion analysis examining associations between the PETS health care 
workload domain and the demographic and clinical variables are 
shown.
Workload related to accessing medical information was signifi-
cantly	associated	with	education	level	(RM:	0.72,	95%	CI:	0.56–	0.93,	
p	=	0.013),	that	is,	patients	with	higher	education	levels	had	a	26%	
lower expected score. Workload related to managing medical ap-
pointments	was	 significantly	 associated	with	 age,	with	 a	 12%	de-
crease	 in	 the	 anticipated	 sub-	score	 per	 5-	year	 age	 increase	 (RM:	
0.88,	95%	CI:	0.78–	0.98,	p = 0.024). Workload related to monitoring 
health	was	significantly	associated	with	age	(RM:	0.90,	95%	CI:	0.81–	
1.00, p	=	0.046),	with	a	10%	reduction	per	5-	year	 increase	 in	age,	
and	with	living	conditions	(RM:	1.70,	95%	CI:	1.01–	2.87,	p = 0.047), 
with	patients	 living	alone	having	a	70%	higher	expected	sub-	score	
than those living with others.
No	 significant	 associations	were	 found	 between	 the	workload	
of	health	care	and	gender,	employment	status,	Dukes	cancer	stage,	
treatment mode, comorbidity or time since primary surgery.
TA B L E  5 Unadjusted	and	adjusted	associations	between	the	demographic	and	clinical	variables	and	the	PETS	impact	domain
Variables
Role and social activity limitations (n = 126) Physical and mental fatigue (n = 126)
Unadjusted Adjusted (n = 125) Unadjusted Adjusted (n = 126)
RM (95% CI) p RM (95% CI) P RM (95% CI) P RM (95% CI) p
Time since primary surgical treatment (ref. <6 months)
6– 12 months 0.76 (0.49, 
1.19)
0.23 0.71 (0.47, 
1.06)
0.095 1.08 (0.83, 
1.40)
0.58 1.03 (0.81, 
1.29)
0.83
>12	months 0.50 (0.29, 
0.89)
0.017 0.57 (0.35, 
0.91)
0.019 1.02 (0.76, 1.38) 0.88 1.07 (0.83, 
1.36)
0.61
Female	vs.	male 1.01 (0.69, 
1.46)
0.97 0.98 (0.69, 
1.38)
0.70 1.22	(0.97,	1.53) 0.089 1.23 (1.00, 
1.50)
0.050
Age	per	5	years 0.82 (0.76, 
0.88)
<0.001 0.79 (0.73, 
0.85)
<0.001 0.92 (0.87, 0.97) 0.002 0.90 (0.85, 
0.95)
<0.001




0.94 1.68 (1.13, 
2.52)
0.011 1.00 (0.71, 1.41) 0.99 1.02 (0.74, 
1.40)
0.91














0.24 – – 1.02 (0.81, 
1.28)n = 122
0.89 – – 
Comorbidities (ref. 0 comorbidities)
1 comorbidity 0.91	(0.59,	
1.42)
0.69 1.18 (0.82, 
1.70)
0.38 0.95	(0.72,	1.26) 0.73 1.08 (0.83, 
1.41)
0.55
2 comorbidities 0.72 (0.40, 
1.30)
0.28 1.26 (0.69, 
2.30)









0.21 0.74	(0.50,	1.10) 0.13 0.84	(0.58,	
1.22)
0.35
4 or more comorbidities 1.36	(0.85,	
2.16)
0.20 2.05 (1.28, 
3.27)








0.29 0.71 (0.52, 0.97) 0.030 0.67 (0.51, 
0.88)
0.004
Dukes’	C 1.11 (0.72, 
1.72)
0.63 0.80 (0.49, 
1.33)







0.038 1.32 (0.78, 
2.24)




Bold values indicate associations of significance p	=	0.05.
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3.3  |  Treatment burden stressors and their 
associations with demographic and clinical 
characteristics
The unadjusted and adjusted results from the regression analysis 
examining associations between stressors aggravating the burden 
and the demographic and clinical variables are shown in Table 4. 
There was a significant association between the stressor ‘medical 
and	 health	 care	 expenses’	 and	 age	 (RM:	 0.85,	 95%	CI:	 0.76–	0.96,	
p	=	0.006),	with	a	decrease	in	the	expected	score	of	15%	per	5-	year	
age	increase,	and	education	(RM:	0.49,	95%	CI:	0.28,	0.88,	p = 0.016), 
with	patients	with	higher	education	 levels	having	a	51%	 lower	ex-
pected sub- score. Patients with higher education levels also had a 
34%	lower	expected	score	for	the	stressor	 ‘difficulties	with	health	
care	 services’	 (RM:	 0.66,	 95%	 CI:	 0.47–	0.92,	 p = 0.016). Patients 
with	≥4	comorbid	conditions	had	an	expected	subscale	score	for	the	
stressor ‘relations with others’ that was three times higher than that 
of	patients	with	no	comorbid	conditions	 (RM:	3.04,	95%	CI:	1.26–	
7.32, p = 0.013).
No	significant	associations	were	found	between	stressors	aggra-
vating treatment burden and gender, living conditions, employment 
status,	Dukes	cancer	stage,	treatment	mode	or	time	since	primary	
surgical treatment.
3.4  |  Impact from treatment burden and 
its associations with demographic and clinical 
characteristics
Table	5	displays	the	unadjusted	and	adjusted	results	from	the	regres-
sion analysis examining associations between impact from the burden 
and the demographic and clinical variables. Significant associations 





CI: 1.28– 3.27, p	=	0.003),	with	patients	with	≥4	comorbid	conditions	
having expected sub- scores twice as high as those of patients with 
no comorbid conditions.
Significant associations were found between ‘physical and men-
tal	fatigue’	and	gender	(RM:	1.23,	95%	CI:	1.00–	1.50,	p	=	0.050),	with	
female	patients	having	expected	 scores	23%	higher	 than	 those	of	
male	patients;	age	(RM:	0.90,	95%	CI:	0.85–	0.95,	p = <0.001), with 
10%	lower	scores	per	5-	year	age	increase;	education	level	(RM:	0.68,	




Employment status and time since primary surgical treatment 
were not significantly associated with the impact domain of treat-
ment burden.
4  |  DISCUSSION
This study describes the perceived burden of CRC treatment and 
self- management and differences in aspects of this burden (i.e. 
workload, stressors and impact) between groups according to de-
mographic and clinical characteristics as well as time since primary 
surgery.
The results identified that CRC subpopulations who are younger, 
have low education levels and have no cohabitants experience higher 
burden in three workload dimensions, that is, assessing medical infor-
mation, medical appointments and monitoring health. In our study, 
younger age was associated with experiencing a higher burden of or-
ganising	medical	appointments.	A	likely	explanation	is	that	the	disease	
interferes more with the daily life of younger cancer patients or that 
their situation is in greater contrast to the expectations of their life situ-
ation. Younger CRC patients often have more extraordinary work- and 
family- related responsibilities, leaving less time for self- management 
tasks,	such	as	organising	medical	appointments	(Mansfield	et	al.,	2018).
Our	observations	suggest	that	low	education	is	a	risk	factor	for	
having difficulties accessing medical information needed to cope 
with the illness and treatment regimens. In previous research, ed-
ucation level is acknowledged as an important predictor of health 
literacy and are found to predict positive coping behaviour in CRC 
patients (Jin et al., 2019). In addition, a low education level was 
significantly	 associated	 with	 stress	 from	 dealing	 with	 ‘Difficulties	
with health care services’, a self- management task required to stay 
healthy and avoid illness deterioration and that, if not managed ef-
fectively, may result in poor care coordination and overwhelmed pa-
tients	(Durcinoska	et	al.,	2017).	CRC	patients	can	benefit	from	health	
information being made readily available before and after surgical 
treatment	 (Jin	et	al.,	2019).	Furthermore,	evaluating	CRC	patients’	
health literacy levels and information needs in the early stages of 
primary therapy, and adapt information given the individual patient 
might ameliorate feelings of self- management burden, and facilitate 
navigating the healthcare system throughout the illness trajectory.
Cancer survivors may experience uncertainty and increased stress 
associated with self- monitoring of symptoms and changes in health 
condition	(Muntlin	Athlin	et	al.,	2018).	In	line	with	this,	findings	from	
our study indicate burden from monitoring health was among the 
essential sources of BoT, especially among young patients. CRC inci-
dence is growing in younger adults (Cavestro et al., 2018), and younger 
patients more often encounter advanced disease and more likely to 
undergo adjuvant chemotherapy than older patients (Rodriguez et al., 
2018). Kotronoulas et al. (2017) identified younger age as a significant 
predictor of unaddressed care needs following CRC surgery due to less 
experience with coping with long- term conditions. The results showed 
that burden from monitoring health was also more present in CRC pa-
tients living alone, most likely due to the lack of a close person with 
whom to share the treatment burden, access to emotional support and 
concerns about illness deterioration. Younger individuals and those 
without cohabitants should be targeted for additional, personalised 
help with monitoring routines and reassurance regarding recovery.
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Our	results	indicate	that	younger	patients	are	more	vulnerable	to	
the healthcare- related financial burden of CRC. Younger age at the 
time of cancer diagnosis can cause higher financial distress because 
younger people have fewer assets and fewer savings and an eco-
nomically demanding work and family life situation (Snyder & Chang, 
2019).	Even	in	a	high-	income	country	such	as	Norway,	where	health-
care services to a large extent are refunded, younger CRC patients 
may need help to develop financial plans.
Facing	 a	 cancer	 diagnosis	 involving	 upcoming	 treatments	may	
be overwhelming to many cancer patients and create feelings of 
helplessness, insecurity and decreased role competency in relation-
ships	with	others	 (Grassi	&	Nanni,	2016).	Our	 results	suggest	 that	
particularly in CRC patients with multimorbidity, treatment burden 
may be more pronounced due to stressful relationships with oth-
ers	 and	 limit	 their	 social	 life.	Many	 cancer	 patients	 are	 often	 co-
morbid, and this adds to the workload created by cancer treatment 
and	self-	management	(Snyder	et	al.,	2015).	This	in	turn	may	create	
more tension in close relations, and patients may experience a lack 
of a supportive environment for self- management. Eton et al. (2019) 
found that having multiple chronic conditions represented a limita-
tion to cancer survivors’ role and social activity involvement.
Several CRC patient subgroups experienced higher levels of 
physical and mental fatigue due to self- management. The findings 
that younger CRC patients and those with a low education level ex-
perienced more fatigue from self- management reflects our results 
on the treatment burden dimensions of workload and stressors. The 
self- management tasks of accessing medical information, monitoring 
health and engaging with healthcare services and stress related to 
medical expenses and in close relations may overwhelm some pa-
tients. Health professionals should include screening measures to 
predict CRC patients at risk of being overwhelmed by treatment 
burden.	Although	gender	did	not	appear	 to	be	a	decisive	factor	 in	
how CRC patients experienced treatment burden, females reported 
higher	 fatigue	 levels	 than	males.	Our	 findings	 support	 the	 notion	
that variations may be more significant within genders than between 
genders. However, it is essential to include gender as a determinant 
of	self-	management	capacity	(Peate,	2015).
In this study, a patient's cancer stage was significantly associated 
with fatigue due to self- management. Surprisingly, no significant dif-
ference was identified in self- management fatigue between patients 
diagnosed	with	Dukes’	C	and	patients	with	Dukes’	A	cancer	stage.	
Compared	to	 those	with	a	Dukes’	A	stage,	patients	with	Dukes’	C	
stage	 (i.e.	Node-	positive	 tumours)	 require	 adjuvant	 treatment	 and	
a cancer treatment pathway of longer duration, most likely expos-
ing	 the	 patient	 to	 a	 higher	 treatment	 burden.	On	 the	 other	 hand,	
patients	with	Dukes’	C	were	 being	 followed	up	 by	 the	 outpatient	
clinic. Thus, these patients may experience more self- management 
support and may not experience fatigue related to undertaking self- 
management. Perceiving antitumor treatment as useful has been 
shown to have a positive impact on cancer patients’ quality of life, a 
belief that warrants a supportive and trusting relationship with can-




and consequently, low explanatory power may have increased the 
risk of type II errors. Second, the study was completed at a single 
institution with a population- based referral pattern of consecutive 
patients, so the generalisability of the results to other geographic 
regions may still be questionable. Third, the study inclusion criteria 
of age between 18 and 79 years excluded the treatment burden 
experiences	 of	 CRC	 patients	 ≥	 80	 years	 of	 age.	 Fourth,	 the	 psy-
chometric	properties	of	 the	Norwegian	version	of	 the	PETS	have	
yet to be assessed before satisfactory levels of reliability can be 
confirmed. This study shows modest levels of treatment burden in 
this CRC sample, which may be due to the appropriateness of PETS 
for capturing patients’ treatment burden. The original version of the 
PETS was developed and validated in multi- morbid patient popula-
tions (Eton et al., 2017), and further research is warranted to fur-
ther establish the applicability of the PETS in cancer populations. 
Nonetheless,	 the	 study	 includes	 treatment	 burden	 self-	reported	
data and from CRC patients only, which may be considered a 
strength.
5  |  CONCLUSIONS
This survey of treatment burden has provided new knowledge on 
self- management workload, stressors contributing to burden, and 
how treatment burden affects patients with CRC. It also identified 
potential subgroups of patients in need of special attention for ame-
liorating their treatment burden. The overall treatment burden lev-
els of CRC patients were modest and associated with age, gender, 
education level, living conditions, multimorbidity and cancer stage. 
To identify CRC subpopulations at risk of treatment burden, there 
is a need to incorporate screening of patients’ self- management 
challenges and treatment burden experiences throughout the can-
cer treatment pathway. Support should be adapted to identified 
self- management challenges and treatment burden. Information on 
treatment burden may provide a better understanding of the work 
required by CRC patients to self- manage following primary treat-
ment and the conditions most likely to influence patients’ ability 
to self- manage. In general, more research is needed on CRC treat-
ment burden to develop interventions customised to meet patients’ 
support needs following primary treatment and optimise self- 
management in vulnerable subpopulations.
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